USP22‐mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
USP22‐mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-11-07
DOI
10.1002/1878-0261.13137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer
- (2021) Wenjie Su et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Ginsenoside Rg3 suppresses the growth of gemcitabine‐resistant pancreatic cancer cells by upregulating lncRNA‐CASC2 and activating PTEN signaling
- (2020) Jifeng Zou et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- A premalignant cell-based model for functionalization and classification of PTEN variants
- (2020) Jesse T. Chao et al. CANCER RESEARCH
- USP22 positively modulates ERα action via its deubiquitinase activity in breast cancer
- (2020) Shengli Wang et al. CELL DEATH AND DIFFERENTIATION
- MDM2 inhibition: an important step forward in cancer therapy
- (2020) Marina Konopleva et al. LEUKEMIA
- Aflatoxin B1 Induces Neurotoxicity through Reactive Oxygen Species Generation, DNA Damage, Apoptosis, and S-Phase Cell Cycle Arrest
- (2020) Boyan Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT–GSK-3β–β-Catenin Signaling Pathway
- (2020) Shiyu Chen et al. Frontiers in Oncology
- Expression of the PTEN/FOXO3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression
- (2019) Qiubo Zhang et al. INVESTIGATIONAL NEW DRUGS
- miR-486 Promotes Capan-2 Pancreatic Cancer Cell Proliferation by Targeting Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)
- (2019) Lu Xia et al. Frontiers in Genetics
- USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity
- (2019) Robyn Laura Kosinsky et al. CELL DEATH AND DIFFERENTIATION
- Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling
- (2019) Hongxia Liu et al. Aging-US
- USP22 functions as an oncogenic driver in prostate cancer by regulating cell proliferation and DNA repair
- (2019) Jennifer J McCann et al. CANCER RESEARCH
- Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to promote pancreatic cancer metastasis
- (2018) Xiaofeng Wang et al. CANCER RESEARCH
- A genome-wide RNAi screen identifies MASK as a positive regulator of cytokine receptor stability
- (2018) Katherine H. Fisher et al. JOURNAL OF CELL SCIENCE
- The functions and regulation of the PTEN tumour suppressor: new modes and prospects
- (2018) Yu-Ru Lee et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- p21: A Two-Faced Genome Guardian
- (2017) Alexandros G. Georgakilas et al. TRENDS IN MOLECULAR MEDICINE
- Targeting the MDM2–p53 Protein–Protein Interaction for New Cancer Therapy: Progress and Challenges
- (2017) Shaomeng Wang et al. Cold Spring Harbor Perspectives in Medicine
- ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells
- (2015) João Agostinho Machado-Neto et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- KH–RNA interactions: back in the groove
- (2015) Giuseppe Nicastro et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth
- (2015) Anamika Dhyani et al. EUROPEAN JOURNAL OF CANCER
- The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents
- (2015) J. Canon et al. MOLECULAR CANCER THERAPEUTICS
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- (2014) João Agostinho Machado-Neto et al. EXPERIMENTAL CELL RESEARCH
- Mask Proteins Are Cofactors of Yorkie/YAP in the Hippo Pathway
- (2013) Clara M. Sidor et al. CURRENT BIOLOGY
- Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells
- (2013) João Agostinho Machado-Neto et al. LEUKEMIA RESEARCH
- ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells
- (2012) Anamika Dhyani et al. FEBS LETTERS
- The functions and regulation of the PTEN tumour suppressor
- (2012) Min Sup Song et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A continuum model for tumour suppression
- (2011) Alice H. Berger et al. NATURE
- Non-genomic loss of PTEN function in cancer: not in my genes
- (2011) Nick R. Leslie et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Oncogenic Role of the E3 Ubiquitin Ligase NEDD4-1, a PTEN Negative Regulator, in Non-Small-Cell Lung Carcinomas
- (2010) Nicola Amodio et al. AMERICAN JOURNAL OF PATHOLOGY
- Tissue Transglutaminase Regulates Focal Adhesion Kinase/AKT Activation by Modulating PTEN Expression in Pancreatic Cancer Cells
- (2008) A. Verma et al. CLINICAL CANCER RESEARCH
- Structure and function of KH domains
- (2008) Roberto Valverde et al. FEBS Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now